PointState Capital’s AstraZeneca AZN Stock Holding History

PointState Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-33,675	Closed	-$4.45M	–	51
2022 Q2	$4.45M	Buy	+33,675	New	+$4.42M	0.17%	45
2022 Q1	–	Hold	0	–	–	–	80
2021 Q4	–	Sell	-410,950	Closed	-$48.4M	–	125
2021 Q3	$49.4M	Buy	410,950 +76,755	+23%	+$8.93M	1.17%	32
2021 Q2	$40M	Sell	334,195 -100,412	-23%	-$11M	0.95%	48
2021 Q1	$43.2M	Buy	434,607 +367,107	+544%	+$36.9M	1.2%	44
2020 Q4	$6.75M	Buy	+67,500	New	+$7.15M	0.17%	84
2018 Q2	–	Sell	-143,650	Closed	-$10M	–	162
2018 Q1	$10M	Buy	+143,650	New	+$9.95M	0.12%	99

Other funds holding AZN

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

CIBC Private Wealth Group

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return